492 related articles for article (PubMed ID: 22252444)
21. Strategies for production of active eukaryotic proteins in bacterial expression system.
Khow O; Suntrarachun S
Asian Pac J Trop Biomed; 2012 Feb; 2(2):159-62. PubMed ID: 23569889
[TBL] [Abstract][Full Text] [Related]
22. Strategies for the production of recombinant protein in Escherichia coli.
Gopal GJ; Kumar A
Protein J; 2013 Aug; 32(6):419-25. PubMed ID: 23897421
[TBL] [Abstract][Full Text] [Related]
23. Recent developments in heterologous protein production in Escherichia coli.
Hockney RC
Trends Biotechnol; 1994 Nov; 12(11):456-63. PubMed ID: 7765545
[TBL] [Abstract][Full Text] [Related]
24. Systematic metabolic engineering for improvement of glycosylation efficiency in Escherichia coli.
Pandhal J; Desai P; Walpole C; Doroudi L; Malyshev D; Wright PC
Biochem Biophys Res Commun; 2012 Mar; 419(3):472-6. PubMed ID: 22342719
[TBL] [Abstract][Full Text] [Related]
25. Amino acid stabilization for cell-free protein synthesis by modification of the Escherichia coli genome.
Michel-Reydellet N; Calhoun K; Swartz J
Metab Eng; 2004 Jul; 6(3):197-203. PubMed ID: 15256209
[TBL] [Abstract][Full Text] [Related]
26. [Cloning and expression of key genes of butanol synthetic pathway in Escherichia coli].
Zhang Y; Zhou P; Wang P; Xie J; Ye Q
Wei Sheng Wu Xue Bao; 2012 May; 52(5):588-93. PubMed ID: 22803344
[TBL] [Abstract][Full Text] [Related]
27. Genetic engineering modification and fermentation optimization for extracellular production of recombinant proteins using Escherichia coli.
Zhou Y; Lu Z; Wang X; Selvaraj JN; Zhang G
Appl Microbiol Biotechnol; 2018 Feb; 102(4):1545-1556. PubMed ID: 29270732
[TBL] [Abstract][Full Text] [Related]
28. Recombinant protein expression for therapeutic applications.
Andersen DC; Krummen L
Curr Opin Biotechnol; 2002 Apr; 13(2):117-23. PubMed ID: 11950561
[TBL] [Abstract][Full Text] [Related]
29. Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical.
Aldor IS; Krawitz DC; Forrest W; Chen C; Nishihara JC; Joly JC; Champion KM
Appl Environ Microbiol; 2005 Apr; 71(4):1717-28. PubMed ID: 15811994
[TBL] [Abstract][Full Text] [Related]
30. Strategies for efficient production of heterologous proteins in Escherichia coli.
Jana S; Deb JK
Appl Microbiol Biotechnol; 2005 May; 67(3):289-98. PubMed ID: 15635462
[TBL] [Abstract][Full Text] [Related]
31. Metabolic footprint analysis of recombinant Escherichia coli strains during fed-batch fermentations.
Carneiro S; Villas-Bôas SG; Ferreira EC; Rocha I
Mol Biosyst; 2011 Mar; 7(3):899-910. PubMed ID: 21152511
[TBL] [Abstract][Full Text] [Related]
32. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi.
Gerngross TU
Nat Biotechnol; 2004 Nov; 22(11):1409-14. PubMed ID: 15529166
[TBL] [Abstract][Full Text] [Related]
33. Secretory and extracellular production of recombinant proteins using Escherichia coli.
Choi JH; Lee SY
Appl Microbiol Biotechnol; 2004 Jun; 64(5):625-35. PubMed ID: 14966662
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in development of cell-free protein synthesis systems for fast and efficient production of recombinant proteins.
Lee KH; Kim DM
FEMS Microbiol Lett; 2018 Sep; 365(17):. PubMed ID: 30084930
[TBL] [Abstract][Full Text] [Related]
35. Production of glycoprotein vaccines in Escherichia coli.
Ihssen J; Kowarik M; Dilettoso S; Tanner C; Wacker M; Thöny-Meyer L
Microb Cell Fact; 2010 Aug; 9():61. PubMed ID: 20701771
[TBL] [Abstract][Full Text] [Related]
36. Rehosting of bacterial chaperones for high-quality protein production.
Martínez-Alonso M; Toledo-Rubio V; Noad R; Unzueta U; Ferrer-Miralles N; Roy P; Villaverde A
Appl Environ Microbiol; 2009 Dec; 75(24):7850-4. PubMed ID: 19820142
[TBL] [Abstract][Full Text] [Related]
37. Folding of heterologous proteins in bacterial cell factories: Cellular mechanisms and engineering strategies.
Rong Y; Jensen SI; Lindorff-Larsen K; Nielsen AT
Biotechnol Adv; 2023; 63():108079. PubMed ID: 36528238
[TBL] [Abstract][Full Text] [Related]
38. Enhanced production of human full-length immunoglobulin G1 in the periplasm of Escherichia coli.
Lee YJ; Lee DH; Jeong KJ
Appl Microbiol Biotechnol; 2014 Feb; 98(3):1237-46. PubMed ID: 24270917
[TBL] [Abstract][Full Text] [Related]
39. GroEL-GroES assisted folding of multiple recombinant proteins simultaneously over-expressed in Escherichia coli.
Goyal M; Chaudhuri TK
Int J Biochem Cell Biol; 2015 Jul; 64():277-86. PubMed ID: 25957916
[TBL] [Abstract][Full Text] [Related]
40. Use of the uteroglobin platform for the expression of a bivalent antibody against oncofetal fibronectin in Escherichia coli.
Ventura E; Riondato M; Sambuceti G; Salis A; Damonte G; Cordazzo C; Besir H; Pistoia V; Zardi L
PLoS One; 2013; 8(12):e82878. PubMed ID: 24367567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
